Florida, Texas, Virginia, and Ohio Have Seen Sharpest Increase In Physicians Reporting Infections Among HCP Colleagues; Globally, Russia, Mexico, Brazil & Great Britain Have Seen Sharpest Increase
Press Releases
52% of US physicians say country has reached outbreak peak
Majority of Physicians in Many COVID-19 Hotspots Including Korea, Spain, China and Italy Believe Their Countries Have Passed or Reached Outbreak Peak
Kentucky is the Only US State Where More Than 50% of Physicians Recommend Lifting Restrictions Within 2 Weeks
Sermo reports jury is still out on Remdesivir effectivenes
Plasma rated as most safe and effective treatment; 57% of physicians who have used Plasma rate it as highly effective; 60% rate it as safe
Efficacy of treatments as seen by 430 COVID Supertreaters (physicians who’ve treated 20+ COVID patients)
2/3 of U.S. physicians say COVID-19 testing is subpar
As of April 15, 30% of U.S. physicians vs. 60% in Europe reported getting test results back within a day
1/4 of doctors say HCPs should take hydroxychloroquine
Sermo’s Barometer studies have polled over 20,000 physicians globally regarding COVID-19
Doctors report on using Hydroxychloroquine and Azithromycin
Percentage of New York Physicians Who Have Used Hydroxychloroquine Nearly Doubled, Italian and French Physicians Jumped 30% Points + Over 2 Weeks
Plasma Still Perceived as Most Effective but Not Widely Used
Perception of Hydroxychloroquine’s Efficacy is Significantly Higher Among Physicians in Europe and China vs US Physicians (50% vs 29%)
Insight into do-not-resuscitate protocol for COVID patients
69% of hospital physicians globally say their hospitals have already adjusted ventilator prioritization policy in case of shortages; US behind other countries
Zinc and vitamins c, d recommended to treat/prevent COVID
28% advise daily Vitamin C for protection; traditional Chinese medicine used and found effective among nearly half of Chinese physicians
Sermo reports on Hydroxychloroquine, plasma and Remdesivir
Data from week two of largest ongoing international market research study on COVID-19
Sermo doctors reveal global COVID treatment patterns
Sermo Reports on Hydroxychloroquine Efficacy, Rise in Prophylaxis Use; Over 80% Expect 2nd Outbreak
Data from physicians in 30 countries provide COVID insight
5,400+ doctors who have already participated will help create a trusted single source of data that will shape policy, treatment guidelines, and provide real-world insights